GemPharmatech Co (SHSE:688046) Interest Expense : ¥-3.3 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is GemPharmatech Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. GemPharmatech Co's interest expense for the three months ended in Mar. 2024 was ¥ -1.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-3.3 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. GemPharmatech Co's Operating Income for the three months ended in Mar. 2024 was ¥ 29.5 Mil. GemPharmatech Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -1.0 Mil. GemPharmatech Co's Interest Coverage for the quarter that ended in Mar. 2024 was 30.17. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

GemPharmatech Co Interest Expense Historical Data

The historical data trend for GemPharmatech Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemPharmatech Co Interest Expense Chart

GemPharmatech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.26

-0.72

-0.75

-0.50

-2.76

GemPharmatech Co Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial												-0.39	-0.68	-0.75	-0.94	-0.98

GemPharmatech Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-3.3 Mil.

GemPharmatech Co (SHSE:688046) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

GemPharmatech Co's Interest Expense for the three months ended in Mar. 2024 was ¥-1.0 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥29.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥38.3 Mil.

GemPharmatech Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	29.536	/	-0.979
	=	30.17

The higher the ratio, the stronger the company's financial strength is.

GemPharmatech Co (SHSE:688046) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GemPharmatech Co Ltd (SHSE:688046) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032

Website

https://www.gempharmatech.us

GemPharmatech Co Ltd is a provider of?genetically engineered mouse?models?and services to global preclinical research and development communities. It specializes in developing animal models using cutting edge gene-editing technologies with a large collection of?cKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice.

GemPharmatech Co (SHSE:688046) Headlines

No Headlines